| 1 | Biib019 (daclizumab high yield process) | Daclizumab | 1件: D03639D03639 💬 | IL2RA1件: IL2RA 💬 | Cytokine-cytokine receptor interaction11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor | 0131件: 13 💬 | 
| 2 | Biib019 (daclizumab) | Daclizumab | 1件: D03639D03639 💬 | IL2RA1件: IL2RA 💬 | Cytokine-cytokine receptor interaction11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor | 0131件: 13 💬 | 
| 3 | Dac | - | - | - | - | 0133件: 13, 90, 301 💬 | 
| 4 | Dac hyp | - | - | - | - | 0131件: 13 💬 | 
| 5 | Dac-hyp | - | - | - | - | 0131件: 13 💬 | 
| 6 | Dacepton 5 mg/ml | - | - | - | - | 0061件:  6  💬 | 
| 7 | Dacepton 5 mg/ml infuusioneste, liuos | - | - | - | - | 0061件:  6  💬 | 
| 8 | Daclizumab | Daclizumab | 1件: D03639D03639 💬 | IL2RA1件: IL2RA 💬 | Cytokine-cytokine receptor interaction11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor | 0137件: 13, 56, 60, 65, 97, 283, 284 💬 | 
| 9 | Daclizumab (anti-cd25 humanized monoclonal antibody) | Daclizumab | 1件: D03639D03639 💬 | IL2RA1件: IL2RA 💬 | Cytokine-cytokine receptor interaction11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor | 0131件: 13 💬 | 
| 10 | Daclizumab high yield process | Daclizumab | 1件: D03639D03639 💬 | IL2RA1件: IL2RA 💬 | Cytokine-cytokine receptor interaction11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor | 0131件: 13 💬 | 
| 11 | Daclizumab hyp | Daclizumab | 1件: D03639D03639 💬 | IL2RA1件: IL2RA 💬 | Cytokine-cytokine receptor interaction11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor | 0131件: 13 💬 | 
| 12 | Daclizumab hyp (dac hyp | Daclizumab | 1件: D03639D03639 💬 | IL2RA1件: IL2RA 💬 | Cytokine-cytokine receptor interaction11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor | 0131件: 13 💬 | 
| 13 | Daclizumab hyp (dac hyp) | Daclizumab | 1件: D03639D03639 💬 | IL2RA1件: IL2RA 💬 | Cytokine-cytokine receptor interaction11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor | 0131件: 13 💬 | 
| 14 | Daclizumab wih greek suffix | Daclizumab | 1件: D03639D03639 💬 | IL2RA1件: IL2RA 💬 | Cytokine-cytokine receptor interaction11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor | 0131件: 13 💬 | 
| 15 | Daclizumab with greek suufix | Daclizumab | 1件: D03639D03639 💬 | IL2RA1件: IL2RA 💬 | Cytokine-cytokine receptor interaction11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor | 0131件: 13 💬 | 
| 16 | Dacortin | - | - | - | - | 0971件: 97 💬 | 
| 17 | Dacortin ® | - | - | - | - | 0461件: 46 💬 | 
| 18 | Dacortín 2,5mg | - | - | - | - | 2221件: 222 💬 | 
| 19 | Dacortín 30mg | - | - | - | - | 2221件: 222 💬 | 
| 20 | Dacortín 5mg | - | - | - | - | 2221件: 222 💬 | 
| 21 | Decitabine | Decitabine | 1件: D03665D03665 💬 | DNMT13件: DNMT1, DNMT3A, DNMT3B 💬 | Cysteine and methionine metabolism3件: Cysteine and methionine metabolism, Metabolic pathways, MicroRNAs in cancer | 0631件: 63 💬 | 
| 22 | Device: medmont darl adapted chromatic (dac) | - | - | - | - | 0902件: 90, 301 💬 |